The Ledger · Entry 33

Most people with HIV are now on treatment

Share of people living with HIV who receive antiretroviral therapy

1% in 2000
77% in 2024

Data: Our World in Data, based on UNAIDS estimates, via the World Bank

In 2000, antiretroviral therapy existed and worked, but only 1% of the people living with HIV worldwide could get it. The drugs were priced for rich countries, and across the places where the epidemic was worst they were almost entirely out of reach.

Share of people living with HIV who are receiving antiretroviral therapy, 2000 to 2024: from 1% to 77%. Source: Our World in Data, based on UNAIDS estimates, via the World Bank. 1% 2000 24% 2010 47% 2015 77% 2024
Source: Our World in Data, based on UNAIDS estimates, via the World Bank · CC BY 4.0 · retrieved 2026-07-16. Underlying data: UNAIDS estimates, via the World Bank World Development Indicators.

The key rows

2000 1% Almost no one with HIV in poorer countries could get the drugs.
2010 24% The global scale-up gathers pace.
2015 47% Nearly half of those living with HIV are on treatment.
2024 77% More than three in four, the highest on record.

A twenty-year fight over prices, patents, and funding changed that. By 2024, 77% of people living with HIV were on treatment that keeps them healthy and, when it suppresses the virus, stops them passing it on. It is one of the fastest scale-ups of a life-saving medicine ever, and the remaining quarter, often the hardest to reach, is where the epidemic now persists.

Asked often

What share of people with HIV are on treatment?

About 77% of people living with HIV were receiving antiretroviral therapy in 2024, up from just 1% in 2000.

Why does treatment coverage matter for ending HIV?

Antiretroviral therapy keeps people healthy and, when it fully suppresses the virus, prevents transmission. Wider coverage both saves lives and slows new infections.

The world also got better today.

The long lines above are made of single days. We find each day's and send you the proof every morning. Free, forever.